Oral DS107 in Moderate to Severe Atopic Dermatitis

NCT02211417 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Oral DS107
DRUG: Placebo

Sponsor

Dignity Sciences Ltd.